ArticleCancers2024

Adding Anti-HER2 Therapy to Neoadjuvant Endocrine Therapy Seems Effective in Hormone Receptor and HER2 Positive Breast Cancer Patients Unfit for Chemotherapy: A Nationwide Population-Based Cohort Study.

Anne de Bruijn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.